Literature DB >> 34488438

Epidemiologic and Genetic Associations of Erythropoietin With Blood Pressure, Hypertension, and Coronary Artery Disease.

Pengfei Sun1, Nitin Kumar2,3, Adrienne Tin4,5, Jing Zhao1, Michael R Brown6, Zesen Lin7, Min-Lee Yang2,3, Qiwen Zheng8, Jia Jia1, Lawrence F Bielak9, Bing Yu6, Eric Boerwinkle6, Kristina L Hunker2,3, Josef Coresh4, Y Eugene Chen2, Yong Huo1, Sharon L R Kardia9, Rami Khoriaty10, Xiang Zhou11, Alanna C Morrison6, Yan Zhang1,12, Santhi K Ganesh2,3.   

Abstract

[Figure: see text].

Entities:  

Keywords:  coronary artery disease; erythropoietin; hypertension; risk factors

Mesh：

Substances：

Year:  2021        PMID： 34488438      PMCID： PMC8516734          DOI： 10.1161/HYPERTENSIONAHA.121.17597

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


  67 in total

1.  Normalization of hemoglobin level in patients with chronic kidney disease and anemia.

Authors:  Tilman B Drüeke; Francesco Locatelli; Naomi Clyne; Kai-Uwe Eckardt; Iain C Macdougall; Dimitrios Tsakiris; Hans-Ulrich Burger; Armin Scherhag
Journal:  N Engl J Med       Date:  2006-11-16       Impact factor: 91.245

Review 2.  Practical murine hematopathology: a comparative review and implications for research.

Authors:  Karyn E O'Connell; Amy M Mikkola; Aaron M Stepanek; Andyna Vernet; Christopher D Hall; Chia C Sun; Eda Yildirim; John F Staropoli; Jeannie T Lee; Diane E Brown
Journal:  Comp Med       Date:  2015-04       Impact factor: 0.982

3.  High serum erythropoietin level is associated with smaller infarct size in patients with acute myocardial infarction who undergo successful primary percutaneous coronary intervention.

Authors:  Shigeto Namiuchi; Yutaka Kagaya; Jun Ohta; Nobuyuki Shiba; Masafumi Sugi; Masayoshi Oikawa; Hiroyuki Kunii; Hidetsugu Yamao; Nobuo Komatsu; Mitsuru Yui; Hiroko Tada; Masahito Sakuma; Jun Watanabe; Toshikatsu Ichihara; Kunio Shirato
Journal:  J Am Coll Cardiol       Date:  2005-05-03       Impact factor: 24.094

4.  Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization.

Authors:  Christopher Heeschen; Alexandra Aicher; Ralf Lehmann; Stephan Fichtlscherer; Mariuca Vasa; Carmen Urbich; Christiane Mildner-Rihm; Hans Martin; Andreas M Zeiher; Stefanie Dimmeler
Journal:  Blood       Date:  2003-04-17       Impact factor: 22.113

5.  Vadadustat in Patients with Anemia and Non-Dialysis-Dependent CKD.

Authors:  Glenn M Chertow; Pablo E Pergola; Youssef M K Farag; Rajiv Agarwal; Susan Arnold; Gabriel Bako; Geoffrey A Block; Steven Burke; Fausto P Castillo; Alan G Jardine; Zeeshan Khawaja; Mark J Koury; Eldrin F Lewis; Tim Lin; Wenli Luo; Bradley J Maroni; Kunihiro Matsushita; Peter A McCullough; Patrick S Parfrey; Prabir Roy-Chaudhury; Mark J Sarnak; Amit Sharma; Bruce Spinowitz; Carol Tseng; James Tumlin; Dennis L Vargo; Kimberly A Walters; Wolfgang C Winkelmayer; Janet Wittes; Kai-Uwe Eckardt
Journal:  N Engl J Med       Date:  2021-04-29       Impact factor: 91.245

6.  Erythropoietin induces bone marrow and plasma fibroblast growth factor 23 during acute kidney injury.

Authors:  Luis Toro; Víctor Barrientos; Pablo León; Macarena Rojas; Magdalena Gonzalez; Alvaro González-Ibáñez; Sebastián Illanes; Keigo Sugikawa; Néstor Abarzúa; César Bascuñán; Katherine Arcos; Carlos Fuentealba; Ana María Tong; Alvaro A Elorza; María Eugenia Pinto; Rodrigo Alzamora; Carlos Romero; Luis Michea
Journal:  Kidney Int       Date:  2018-02-01       Impact factor: 10.612

7.  The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin.

Authors:  A Besarab; W K Bolton; J K Browne; J C Egrie; A R Nissenson; D M Okamoto; S J Schwab; D A Goodkin
Journal:  N Engl J Med       Date:  1998-08-27       Impact factor: 91.245

Review 8.  Arterial hypertension induced by erythropoietin and erythropoiesis-stimulating agents (ESA).

Authors:  Reto Krapf; Henry N Hulter
Journal:  Clin J Am Soc Nephrol       Date:  2009-02       Impact factor: 8.237

Review 9.  Human high-altitude adaptation: forward genetics meets the HIF pathway.

Authors:  Abigail W Bigham; Frank S Lee
Journal:  Genes Dev       Date:  2014-10-15       Impact factor: 11.361

10.  Erythropoietin in the general population: reference ranges and clinical, biochemical and genetic correlates.

Authors:  Niels Grote Beverborg; Niek Verweij; Ijsbrand T Klip; Haye H van der Wal; Adriaan A Voors; Dirk J van Veldhuisen; Ron T Gansevoort; Stephan J L Bakker; Pim van der Harst; Peter van der Meer
Journal:  PLoS One       Date:  2015-04-27       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.